Loading…
Wilson Sonsini Goodrich & Rosati, P.C.
Active litigationRepresenting the Pioneers and Disruptors Associated with Market-Changing Innovation in Technology and Life Sciences
About
Wilson Sonsini Goodrich & Rosati is a US law firm that its own site states "was founded in Palo Alto in 1961," with Palo Alto identified as the firm's headquarters. The firm describes representing technology pioneers and "life sciences trailblazers" for more than 60 years and ushering technology and life sciences companies through their business life cycle. Its practice groups include Intellectual Property, Patents and Innovations, Post-Grant Review, Regulatory and Litigation, and its listed industries include Biotech, Life Sciences, Medical Devices, Global Generics and Digital Health.
Strategic positioning
IP and corporate strategy built around the venture lifecycle of platform biotech.
Deterministic scores · rules-based, not AI iHow these scores are obtained: each one is computed from this profile's listed attributes — capability checkboxes, certifications, capacity figures and coverage — by a fixed formula, recomputed on every page load. Deterministic and rules-based means the score comes from a fixed, transparent formula over listed attributes — the same inputs always produce the same score. It is not AI: there is no model, no learning, and no hidden weighting. Whether a score is relevant to you depends on your specific project: a capability that raises the number may not matter for your work, and a niche strength your project needs may barely move it. Capability scores are a directional starting point, not a verdict. A lower score does not disqualify a company or consultant, and no decision should rest on the score alone — always contact the company directly to confirm the specifics for your project.
Manufacturing-IP focus iAdds 25 points if the firm declares a manufacturing-IP focus, plus 9 points per manufacturing technology area listed (sterile injectables, biologics, radiopharmaceuticals, biosimilars, drug-device combinations, mRNA/LNP), capped at 45, plus 8 points per manufacturing-IP service (CMC patents, trade secret governance, FTO opinions, patent term extension), capped at 30. Levels: 75+ Manufacturing-IP specialist | 50-74 Manufacturing-active | 25-49 Selective | below 25 Therapeutics-IP focused. Whether this dimension matters for you depends on your specific project.
18Therapeutics-IP focused
Life-sciences IP iAdds 4 points per technology area, capped at 30, plus 5 points per practice area, capped at 25, plus 4 points per jurisdiction, capped at 20, plus up to 25 points for technical depth based on the share of attorneys holding PhDs or advanced degrees. Levels: 80+ Premier life-sciences IP | 60-79 Strong | 40-59 Established | below 40 Emerging. Whether this dimension matters for you depends on your specific project.
52Established
Technology areas
AI drug discoveryCell & gene therapyBiologicsDiagnosticsmRNA / LNP
Practice areas
Patent prosecutionLicensing & tech transferIP due diligencePatent portfolio strategy
Jurisdictions
USPTOEPOWIPO / PCT
WS
Wilson Sonsini Goodrich & Rosati, P.C.
IP & patent counsel · United States
Live record · illustrative seed data · scores deterministic, rules-based — not AI.